Incomplete remyelination via therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function.

By 7 weeks, mice treated with the low dose of LL-341070 had gained substantially more new oligodendrocytes than vehicle-treated mice and a similar trend was observed for the high dose LL-341070, but the differences did not reach statistical significance (Fig. 3H ).

also in 111,027 other papers